Nanoform Finland Plc (HE:NANOFH) — Market Cap & Net Worth
Market Cap & Net Worth: Nanoform Finland Plc (NANOFH)
Nanoform Finland Plc (HE:NANOFH) has a market capitalization of $78.90 Million (€67.49 Million) as of August 28, 2026. Listed on the HE stock exchange, this Finland-based company holds position #20258 globally and #95 in its home market, demonstrating a 3.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nanoform Finland Plc's stock price €0.99 by its total outstanding shares 85669853 (85.67 Million). Check Nanoform Finland Plc (NANOFH) stock price for real-time trading data and today's change.
Nanoform Finland Plc Market Cap History: 2020 to 2026
Nanoform Finland Plc's market capitalization history from 2020 to 2026. Data shows change from $709.11 Million to $99.46 Million (-22.97% CAGR).
Index Memberships
Nanoform Finland Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Finland EUR PI
FNFIEURPI
|
$1.72 Billion | 4.58% | #6 of 25 |
Weight: Nanoform Finland Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nanoform Finland Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nanoform Finland Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check NANOFH net asset value to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
50.05x
Nanoform Finland Plc's market cap is 50.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $709.11 Million | $686.75K | -$19.44 Million | 1032.57x | N/A |
| 2021 | $659.03 Million | $1.95 Million | -$19.69 Million | 337.18x | N/A |
| 2022 | $320.50 Million | $3.49 Million | -$22.07 Million | 91.90x | N/A |
| 2023 | $158.75 Million | $2.57 Million | -$20.76 Million | 61.85x | N/A |
| 2024 | $139.02 Million | $2.78 Million | -$23.43 Million | 50.05x | N/A |
Competitor Companies of NANOFH by Market Capitalization
Companies near Nanoform Finland Plc in the global market cap rankings as of August 28, 2026. Also see cash efficiency ratio of Nanoform Finland Plc for how efficiently the company converts equity into cash flow.
Key companies related to Nanoform Finland Plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #335 globally with a market cap of $81.69 Billion USD.
- CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $59.69 Billion USD ( AU$84.36 Billion AUD).
- Samsung Biologics Co Ltd (KO:207940): Ranked #556 globally with a market cap of $50.00 Billion USD ( ₩73.79 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.55 |
| #335 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $81.69 Billion | $807.71 |
| #459 | CSL Ltd | AU:CSL | $59.69 Billion | AU$173.88 |
| #556 | Samsung Biologics Co Ltd | KO:207940 | $50.00 Billion | ₩1594000.00 |
Nanoform Finland Plc Historical Marketcap From 2020 to 2026
Between 2020 and today, Nanoform Finland Plc's market cap moved from $709.11 Million to $ 99.46 Million, with a yearly change of -22.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €99.46 Million | -15.27% |
| 2025 | €117.38 Million | -15.56% |
| 2024 | €139.02 Million | -12.43% |
| 2023 | €158.75 Million | -50.47% |
| 2022 | €320.50 Million | -51.37% |
| 2021 | €659.03 Million | -7.06% |
| 2020 | €709.11 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 28th, 2026 the market cap of Nanoform Finland Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $78.90 Million USD |
| MoneyControl | $78.90 Million USD |
| MarketWatch | $78.90 Million USD |
| marketcap.company | $78.90 Million USD |
| Reuters | $78.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nanoform Finland Plc
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) na… Read more